Breast Reconstruction Market Drivers
Development and adoption of advanced technologies for breast reconstruction is expected to drive the breast reconstruction market growth. For instance, in March 2016, the breast surgery and reconstructive team at the Valley Health Hospital in Ridgewood, New Jersey (U.S.) used pre-pectoral tissue expander placement technology, which is used for the treatment of breast cancer. Pre-pectoral tissue expander placement technology offers rapid recovery time, improved mobility time, and diminished post-operative pain for patient.
Furthermore, in September 2018, MTF Biologics expanded its portfolio products for breast reconstruction with the launch of Acellular Dermal Matrix (ADM), which is specially designed for pre-pectoral breast reconstruction procedures such as FlexHD Pliable PRE.
Breast Reconstruction Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients